First test of new cholesterol pill in healthy people
NCT ID NCT06857253
Summary
This was an early-stage study to check the safety of a new experimental drug called HRS-1301, which is being developed to treat high cholesterol. It involved 82 healthy volunteers who received either the drug or a placebo. The main goal was to see how well people tolerated the drug and to measure how it moved through and was processed by their bodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.